| Ident. | Authors (with country if any) | Title |
|---|
| 000375 (2011) |
Ewa Orlewska [Pologne] ; Ioan Ancuta [Roumanie] ; Branimir Anic [Croatie] ; Catalin Codrenau [Roumanie] ; Nemanja Damjanov [Serbie] ; Predrag Djukic [Serbie] ; Ruxandra Ionescu [Roumanie] ; Lubomir Marinchev [Bulgarie] ; Evgeny L. Nasonov [Russie] ; Tonu Peets [Estonie] ; Sonja Praprotnik [Slovénie] ; Rasho Rashkov [Bulgarie] ; Jana Skoupa [République tchèque] ; Witold Tlustochowicz [Pologne] ; Malgorzata Tlustochowicz [Pologne] ; Matija Tomsic [Slovénie] ; Tiina Veldi [Estonie] ; Jelena Vojinovic [Serbie] ; Piotr Wiland [Pologne] | Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries |
| 000393 (2011) |
Jerzy Swierkot [Pologne] ; Marta Madej | [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part II. Tocilizumab, Abatacept, Rituximab--drugs characterised by a different mechanism of action than TNF-alpha inhibitors]. |
| 000852 (2013) |
Gerd R. Burmester [Allemagne] ; Andrea Rubbert-Roth [Allemagne] ; Alain Cantagrel [France] ; Stephen Hall [Australie] ; Piotr Leszczynski [Pologne] ; Daniel Feldman [Brésil] ; Madura J. Rangaraj [États-Unis] ; Georgia Roane [États-Unis] ; Charles Ludivico [États-Unis] ; Peng Lu [États-Unis] ; Lucy Rowell [Royaume-Uni] ; Min Bao [États-Unis] ; Eduardo F. Mysler [Argentine] | A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study) |
| 000A06 (2014) |
J S Smolen [Autriche] ; P. Emery [Royaume-Uni] ; G F Ferraccioli ; W. Samborski [Pologne] ; F. Berenbaum [France] ; O R Davies [Belgique] ; W. Koetse [États-Unis] ; O. Purcaru [Belgique] ; B. Bennett [États-Unis] ; H. Burkhardt [Allemagne] | Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial |
| 000B13 (2014) |
Hermine I. Brunner [États-Unis] ; Nicolino Ruperto [Italie] ; Zbigniew Zuber [Pologne] ; Caroline Keane [Royaume-Uni] ; Olivier Harari [Royaume-Uni] ; Andrew Kenwright [Royaume-Uni] ; Peng Lu [États-Unis] ; Ruben Cuttica [Argentine] ; Vladimir Keltsev [Russie] ; Ricardo M. Xavier [Brésil] ; Inmaculada Calvo [Espagne] ; Irina Nikishina [Russie] ; Nadina Rubio-Pérez [Mexique] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Gerd Horneff [Allemagne] ; Violetta Opoka-Winiarska [Pologne] ; Pierre Quartier [France] ; Clovis A. Silva [Brésil] ; Earl Silverman [Canada] ; Alberto Spindler [Argentine] ; Eileen Baildam [Royaume-Uni] ; M Luz Gámir [Espagne] ; Alan Martin [États-Unis] ; Christoph Rietschel [Allemagne] ; Daniel Siri [Argentine] ; Elzbieta Smolewska [Pologne] ; Daniel Lovell [États-Unis] ; Alberto Martini [Italie] ; Fabrizio De Benedetti [Italie] | Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial |
| 000C90 (2015) |
Anna Felis-Giemza [Pologne] ; Marzena Olesi Ska ; Katarzyna Wierkocka ; Ewa Wi Sik-Szewczyk ; Ewa Haładyj | Treatment of rheumatic diseases and hepatitis B virus coinfection. |
| 000D66 (2015) |
Kevin L. Winthrop [États-Unis] ; Joel Silverfield [États-Unis] ; Arthur Racewicz [Pologne] ; Jeffrey Neal [États-Unis] ; Eun Bong Lee [Corée du Sud] ; Pawel Hrycaj [Pologne] ; Juan Gomez-Reino [Espagne] ; Koshika Soma [États-Unis] ; Charles Mebus [États-Unis] ; Bethanie Wilkinson [États-Unis] ; Jennifer Hodge [États-Unis] ; Haiyun Fan [États-Unis] ; Tao Wang [République populaire de Chine] ; Clifton O. Bingham [États-Unis] | The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis |
| 000E39 (2015) |
Gerd R. Burmester [Allemagne] ; Andrea Rubbert-Roth [Allemagne] ; Alain Cantagrel [France] ; Stephen Hall [Australie] ; Piotr Leszczynski [Pologne] ; Daniel Feldman [Brésil] ; Madura J. Rangaraj [États-Unis] ; Georgia Roane [États-Unis] ; Charles Ludivico [États-Unis] ; Min Bao [États-Unis] ; Lucy Rowell [Royaume-Uni] ; Claire Davies [Royaume-Uni] ; Eduardo F. Mysler [Argentine] | Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA) |
| 000F99 (2016) |
Maciej Tarnowski [Pologne] ; Agnieszka Paradowska-Gorycka [Pologne] ; Ewa D Browska-Zamojcin [Pologne] ; Michal Czerewaty [Pologne] ; Sylwia Słuczanowska-Gł Bowska [Pologne] ; Andrzej Pawlik [Pologne] | The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy. |
| 001146 (????) |
Joel M. Kremer [États-Unis] ; Ricardo Blanco [Espagne] ; Anne-Marie Halland [Afrique du Sud] ; Marek Brzosko [Pologne] ; Ruben Burgos-Vargas [Mexique] ; Christopher M. Mela [Royaume-Uni] ; Lucy Rowell [Royaume-Uni] ; Roy M. Fleischmann [États-Unis] | Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial. |
| 001254 (2015) |
Joanna Widrowska [Pologne] ; Agnieszka Zygmunt [Pologne] ; Małgorzata Biernacka-Zieli Ska [Pologne] ; Jerzy Sta Czyk [Pologne] ; El Bieta Smolewska [Pologne] | Influence of biologic therapy on growth in children with chronic inflammatory connective tissue diseases. |
| 001255 (2015) |
Małgorzata Kwiatkowska [Pologne] ; Ewa Jednacz [Pologne] ; Lidia Rutkowska-Sak [Pologne] | Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome - effective treatment with tocilizumab. |
| 001256 (2015) |
Magdalena Chmieli Ska [Pologne] ; Marzena Olesi Ska [Pologne] ; Anna Felis-Giemza [Pologne] | Interleukin 6 blockage-induced neutropenia in a patient with rheumatoid arthritis and resolved hepatitis B. |
| 001899 (2018) |
Joanna Gał Zowska [Pologne] | Interactions between Clinically Used Bisphosphonates and Bone Mineral: from Coordination Chemistry to Biomedical Applications and Beyond. |
| 001A35 (2018) |
Violetta Opoka-Winiarska [Pologne] ; Zbigniew Uber [Pologne] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Irina Nikishina [Russie] ; Gra Yna D Bowska [Pologne] ; El Bieta Smolewska [Pologne] | Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial. |
| 001B56 (2018) |
Maria Kamusheva [Bulgarie] ; Manoela Manova [Bulgarie] ; Alexandra T. Savova [Bulgarie] ; Guenka I. Petrova [Bulgarie] ; Konstantin Mitov [Bulgarie] ; András Harsányi [Hongrie] ; Zoltán Kal [Hongrie] ; Krist F Márky [Hongrie] ; Pawel Kawalec [Pologne] ; Bistra Angelovska [Macédoine (pays)] ; Dragana Laki [Serbie] ; Tomas Tesar [Slovaquie] ; Pero Draganic [Croatie] ; Mary Geitona [Grèce] ; Magdalini Hatzikou [Grèce] ; Marian S. Paveliu [Roumanie] ; Agnes M Nnik [Estonie] | Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries |
| 001C50 (2019) |
Bartosz Urbaniak [Pologne] ; Szymon Plewa [Pologne] ; Agnieszka Klupczynska [Pologne] ; Dorota Sikorska [Pologne] ; Włodzimierz Samborski [Pologne] ; Zenon J. Kokot [Pologne] | Serum free amino acid levels in rheumatoid arthritis according to therapy and physical disability. |
| 001D08 (2018) |
Justyna Roszkiewicz [Pologne] ; Krzysztof Orczyk [Pologne] ; El Bieta Smolewska [Pologne] | Tocilizumab in the treatment of systemic-onset juvenile idiopathic arthritis - single-centre experience. |
| 001F68 (2019) |
Ivan Foeldvari [Allemagne] ; Tamàs Constantin [Hongrie] ; Jelena Vojinovi [Serbie] ; Gerd Horneff [Allemagne] ; Vyacheslav Chasnyk [Russie] ; Joke Dehoorne [Belgique] ; Violeta Panaviene [Lituanie] ; Gordana Suši [Serbie] ; Valda Stanevicha [Lettonie] ; Katarzyna Kobusinska [Pologne] ; Zbigniew Zuber [Pologne] ; Bogna Dobrzyniecka [Pologne] ; Irina Nikishina [Russie] ; Brigitte Bader-Meunier [France] ; Luciana Breda [Italie] ; Pavla Doležalová [République tchèque] ; Chantal Job-Deslandre [France] ; Ingrida Rumba-Rozenfelde [Lettonie] ; Nico Wulffraat [Pays-Bas] ; Ronald D. Pedersen [États-Unis] ; Jack F. Bukowski [États-Unis] ; Bonnie Vlahos [États-Unis] ; Alberto Martini [Italie] ; Nicolino Ruperto [Italie] | Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial |
| 002219 (2019) |
Bartlomiej Wawrzycki [Pologne] ; Dorota Krasowska [Pologne] ; Aldona Pietrzak [Pologne] ; Ewa Wielosz [Pologne] ; Maria Majdan [Pologne] ; Torello Lotti [Italie] | Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab. |
| 002253 (2019) |
Dominik Samotij [Pologne] ; Adam Reich [Pologne] | Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review |
